Relationship between coronary plaque vulnerability and serum n-3/n-6 polyunsaturated fatty acid ratio

Circulation Journal

Volumn 75, Issue 10, 2011, Pages 2432-2438

  Kashiyama, Toshikazu ^a   Ueda, Yasunori ^a   Nemoto, Takayoshi ^a   Wada, Mitsuru ^a   Masumura, Yuki ^a   Matsuo, Koshi ^a   Nishio, Mayu ^a   Hirata, Akio ^a   Asai, Mitsutoshi ^a   Kashiwase, Kazunori ^a   Kodama, Kazuhisa ^a  

^a OSAKA POLICE HOSPITAL   (Japan)

Author keywords

Angioscopy; Eicosapentaenoic acid to arachidonic acid ratio; Plaque vulnerability; Thrombus; Yellow plaque

Indexed keywords

ARACHIDONIC ACID; C REACTIVE PROTEIN; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ACUTE CORONARY SYNDROME; AGED; ANGIOSCOPY; ARTICLE; CARDIOVASCULAR PARAMETERS; CORONARY ANGIOSCOPY; CORONARY PLAQUE VULNERABILITY; DISEASE ASSOCIATION; FATTY ACID ANALYSIS; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; ICOSAPENTAENOIC ACID TO ARACHIDONIC ACID RATIO; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; SCORING SYSTEM; STABLE ANGINA PECTORIS; THROMBUS; YELLOW COLOR CORONARY PLAQUE GRADE;

AGED; ARACHIDONIC ACID; COLOR; CORONARY THROMBOSIS; DISEASE SUSCEPTIBILITY; EICOSAPENTAENOIC ACID; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FEMALE; HUMANS; MALE; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC;

EID: 80053082462     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-11-0352     Document Type: Article

References (24)

1. Dyerberg J, Bang HO, Stoffersen E, Moncada S, Vane JR. Eicosap-entaenoic acid and prevention of thrombosis and atherosclerosis? Lancet 1978; 2: 117-119
2. Nakamura T, Azuma A, Kuribayashi T, Sugihara H, Okuda S, Nakagawa M. Serum fatty acid levels, dietary style and coronary heart disease in three neighbouring areas in Japan: The Kumihama study. Br J Nutr 2003; 89: 267-272
3. Marik PE, Varon J. Omega-3 dietary supplements and the risk of cardiovascular events: A systematic review. Clin Cardiol 2009; 32: 365-372
4. Domei T, Ueeda M, Takaya Y, Ohnishi N, Takaishi A, Imai M, et al. The balance of n6/n3 polyunsaturated fatty acid (PUFAs) is important factor of prognosis after acute myocardial infarction. Circulation 2006; 114: 2-463
5. Domei T, Kuramitsu S, Ando K, Soga Y, Arita T, Shirai S, et al. The relationship between the ratio of serum eicosapentaenoic acid (EPA) to arachidonic acid (AA) with major cardiac events in patients under- going elective percutaneous coronary intervention. Circulation 2009; 120: S426
6. Matsuzaki M, Yokoyama M, Saito Y, Origasa H, Ishikawa Y, Oikawa S, et al; for the JELIS Investigators, Japan. Incremental effects of eicosapentaenoic acid on cardiovascular events in statin-treated patients with coronary artery disease: Secondary prevention analysis from JELIS. Circ J 2009; 73: 1283-1290
7. Lavie CJ, Milani RV, Mehra MR, Ventura HO. Omega-3 polyun-saturated fatty acids and cardiovascular diseases. J Am Coll Cardiol 2009; 54: 585-594
8. Saito Y, Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Ishikawa Y, et al; JELIS Investigators, Japan. Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: Sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS). Atherosclerosis 2008; 200: 135-140
9. Mita T, Watada H, Ogihara T, Nomiyama T, Ogawa O, Kinoshita J, et al. Eicosapentaenoic acid reduces the progression of carotid intima-media thickness in patients with type 2 diabetes. Atherosclerosis 2007; 191: 162-167
10. Tanaka K, Ishikawa Y, Yokoyama M, Origasa H, Matsuzaki M, Saito Y, et al; JELIS Investigators, Japan. Reduction in the recurrence of stroke by eicosapentaenoic acid for hypercholesterolemic patients: Subanalysis of the JELIS trial. Stroke 2008; 39: 2052-2058
11. Ueda Y, Ohtani T, Shimizu M, Hirayama A, Kodama K. Assessment of plaque vulnerability by angioscopic classification of plaque color. Am Heart J 2004; 148: 333-335
12. Virmani R, Burke AP, Kolodgie FD, Farb A. Vulnerable plaque: The pathology of unstable coronary lesions. J Interv Cardiol 2002; 15: 439-446
13. Kubo T, Imanishi T, Takarada S, Kuroi A, Ueno S, Yamano T, et al. Implication of plaque color classification for assessing plaque vulnerability: A coronary angioscopy and optical coherence tomography investigation. JACC Cardiovasc Interv 2008; 1: 74-80
14. Ueda Y, Asakura M, Yamaguchi O, Hirayama A, Hori M, Kodama K. The healing process of infarct-related plaques: Insights from 18 months of serial angioscopic follow-up. J Am Coll Cardiol 2001; 38: 1916-1922
15. Ueda Y, Ogasawara N, Matsuo K, Hirotani S, Kashiwase K, Hirata A, et al. Acute coronary syndrome: Insight from angioscopy. Circ J 2010; 74: 411-417
16. Sanidas EA, Maehara A, Mintz GS, Kashiyama T, Guo J, Pu J, et al. Angioscopic and virtual histology intravascular ultrasound characteristics of culprit lesion morphology underlying coronary artery thrombosis. Am J Cardiol 2011; 107: 1285-1290
17. Ueda Y, Nanto S, Komamura K, Kodama K. Neointimal coverage of stents in human coronary arteries observed by angioscopy. J Am Coll Cardiol 1994; 23: 341-346
18. Gajos G, Rostoff P, Undas A, Piwowarska W. Effects of polyunsaturated omega-3 fatty acids on responsiveness to dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: The OMEGA-PCI (OMEGA-3 fatty acids after PCI to modify responsiveness to dual antiplatelet therapy) study. J Am Coll Cardiol 2010; 55: 1671-1678
19. Satoh N, Shimatsu A, Kotani K, Sakane N, Yamada K, Suganami T, et al. Purified eicosapentaenoic acid reduces small dense LDL, remnant lipoprotein particles, and C-reactive protein in metabolic syndrome. Diabetes Care 2007; 30: 144-146
20. Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y, et al; Japan EPA lipid intervention study (JELIS) Investigators. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): A randomised open-label, blinded endpoint analysis. Lancet 2007; 369: 1090-1098
21. Calder PC. N-3 polyunsaturated fatty acids and inflammation: From molecular biology to the clinic. Lipids 2003; 38: 343-352
22. Ueeda M, Doumei T, Takaya Y, Shinohata R, Katayama Y, Ohnishi N, et al. Serum N-3 polyunsaturated fatty acid levels correlate with the extent of coronary plaques and calcifications in patients with acute myocardial infarction. Circ J 2008; 72: 1836-1843
23. Kodama K, Komatsu S, Ueda Y, Takayama T, Yajima J, Nanto S, et al. Stabilization and regression of coronary plaques treated with pitavastatin proven by angioscopy and intravascular ultrasound: The TOGETHAR trial. Circ J 2010; 74: 1922-1928
24. Okada K, Ueda Y, Matsuo K, Nishio M, Hirata A, Kashiwase K, et al. Frequency and healing of nonculprit coronary artery plaque disruptions in patients with acute myocardial infarction. Am J Cardiol 2011; 107: 1426-1429